Antibiotics double bleed risk in patients on warfarin
- Elderly missing out on warfarin therapy. // Pulse;11/7/2012, Vol. 72 Issue 36, p14
The article informs the ratio of elderly patients going for warfarin therapy is less as compared to the younger group despite the fact that their age puts them at higher risk of bleeding, as warned by the researchers in Great Britain.
- Bleeding risk with warfarin is high among elderly. // Journal of Family Practice;Sep2007, Vol. 56 Issue 9, p709
The article presents question and answer concerning the risk offered by warfarin, an anticoagulant medication, to older patients. A study reveals that warfarin offers an increased risk to bleeding or hemmorhage after receiving the treatment. It was inferred that increased bleeding from among the...
- Adverse drug events in the elderly. // Infectious Disease Alert;Jan2012 Pharmacology Watch, p2
The article discusses a study on the dangerous effect of warfarin and other common medications on elderly patients.
- EPHX1 Polymorphisms Are Not Associated With Warfarin Response in an Italian Population. Ciccacci, C.; Paolillo, N.; Di Fusco, D.; Novelli, G.; Borgiani, P. // Clinical Pharmacology & Therapeutics;Jun2011, Vol. 89 Issue 6, p791
A letter to the editor is presented in response to the article "Genetic Factors (VKORC1, CYP2C9, EPHX1, and CYP4F2) Are Predictor Variables for Warfarin Response in Very Elderly, Frail Inpatients," by E. Pautas and colleagues in the 2010 issue.
- Anticoagulant Therapy in Very Old Patients. Davila, Rafael G. // Cardiovascular & Haematological Disorders - Drug Targets;Mar2011, Vol. 11 Issue 1, p24
No abstract available.
- Risk of Major Hemorrhage for Outpatients Treated with Warfarin. McMahan, Deborah A.; Smith, David M.; Carey, Mark A.; Zhou, Xiao Hua; McMahan // JGIM: Journal of General Internal Medicine;May1998, Vol. 13 Issue 5, p311
OBJECTIVE:To determine the incidence of major hemorrhage among outpatients started on warfarin therapy after the recommendation in 1986 for reduced-intensity anticoagulation therapy was made, and to identify baseline patient characteristics that predict those patients who will have a major...
- Pharmacists' involvement in warfarin therapy reduced total bleeding by half. Cona, Christen; Harris, Jason; Southall, Jennifer // Hem/Onc Today;10/25/2010, Vol. 11 Issue 20, p27
The article discusses research being done on the effectiveness of pharmacist-participated warfarin treatment in reducing total bleeding, which references a study by Surasak Saokaer and colleagues in a 2010 issue of the "Journal of Thrombosis and Haemostasis."
- Warfarin and intracranial hemorrhage. Hylek, EM; Singer, DE // Patient Care;9/30/1994, Vol. 28 Issue 15, p102
Reports that a prothrombin time ratio (PTR) of less than 2.0 is essential in patients taking warfarin. Findings of researchers at the Massachusetts General Hospital; Description of the study group; Risk of intracerebral hemorrhage; Predictors of intracerebral hemorrhage.
- Warfarin-based genotyping not cost effective for most patients. // Hem/Onc Today;3/10/2009, Vol. 10 Issue 5, p32
The article discusses research on the degree to which pharmacogenetic-guided dosing of warfarin improved risk for major bleeding compared to standard induction treatment with warfarin, published in the 2009 issue of the "Annals of Internal Medicine."